Should Investors Buy KEYS as Growth Surges but Valuation Looks Mixed?

Keysight expects fiscal 2026 revenue growth of 32% and earnings growth of 59.9%, after Q3 revenue rose 36% year over year to $1.846 billion and non-GAAP EPS increased to $3.07 from $1.72. Current-year EPS estimates rose 14.3% in four weeks and next-quarter estimates increased 27.7%, supported by AI infrastructure, communications and semiconductor demand. The investment case remains balanced: KEYS trades at 22.6x forward earnings, below its 24.02x five-year median but above the 20.4x technology-sector and 19.8x S&P 500 multiples, while China, tariff, supply and recurring-revenue-mix risks persist.

Analysis

KEYS is transitioning from a recurring-software-heavy mix toward higher-throughput instrument shipments, which can drive near-term operating leverage but also makes quarterly results more exposed to delivery timing, component availability and customer capex digestion. The key underwriting question is whether AI test demand represents a multi-year content-per-device expansion—particularly in high-speed interconnect, photonics and power—or a one-to-two-quarter capacity catch-up. If backlog conversion remains strong while gross margin holds, consensus has likely not fully modeled the incremental earnings power from acquired-cost synergies and lower share count.

The second-order beneficiary is ATEYY, where leading-edge compute test spending should remain supported even if end-market unit growth slows; however, KEYS and ATEYY are not clean substitutes. KEYS is more leveraged to communications, network validation and electronic design test, while ATEYY is more directly tied to semiconductor test intensity. CDNS benefits structurally from rising verification complexity, but its subscription model should be less sensitive to near-term hardware shipment timing; a long KEYS/short CDNS pair would therefore express a cyclical AI-infrastructure acceleration view, not a broad AI view.

Near term, upward revisions and buybacks can sustain relative strength for 1-3 months, but the stock needs evidence that product-led growth does not permanently dilute the higher-quality recurring-revenue mix. The contrarian risk is that the market treats the current multiple as inexpensive versus history while overlooking a lower-quality revenue composition and heightened China/export-control optionality. A miss in orders, a material reduction in AI-related backlog, or gross-margin pressure despite synergy realization would likely cause multiple compression faster than earnings estimates reset.

The tariff-refund receivable should not be capitalized in the base case: it is a one-time balance-sheet upside rather than an operating catalyst. More important over 6-18 months is whether management can translate supply-constrained demand into pricing rather than simply volume; sustained price/mix gains would differentiate KEYS from a typical test-equipment upcycle and justify a premium to broader technology multiples.

Key Decisions for Investors

• Initiate a measured long KEYS only after confirming the next order/backlog update shows continued AI-related growth and stable or improving gross margin; target a 6-12 month holding period. Underwrite roughly 15-20% upside from estimate revisions plus modest multiple expansion, versus 10-12% downside if forward EPS revisions flatten and the multiple derates toward the broad technology sector.
• Use a long KEYS / short CDNS equal-dollar pair for the next 1-3 months if seeking to isolate hardware-test cycle acceleration from general AI sentiment. Exit if KEYS order growth decelerates materially or if CDNS raises guidance on design/verification demand, which would signal the spend cycle is shifting upstream rather than broadening.
• Prefer ATEYY over KEYS for investors seeking purer leading-edge semiconductor test exposure; retain KEYS for communications, photonics and network-validation exposure. Do not treat the names as interchangeable, and reassess relative positioning after each company's next guidance cycle.
• Set a downside alert around any sequential decline in product gross margin, recurring-revenue mix deterioration beyond the current level, or commentary that supply constraints are limiting revenue conversion rather than easing. Any of these would falsify the operating-leverage thesis and warrant reducing KEYS before the next earnings print.
• Do not add on tariff-refund headlines alone. Treat recovery as non-core upside; require evidence of durable pricing, backlog conversion and synergy capture before increasing exposure.